Pamlab, Inc.

🇺🇸United States
Ownership
Subsidiary
Established
1957-01-01
Employees
251
Market Cap
-
Website
http://www.pamlab.com

The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)

First Posted Date
2013-11-21
Last Posted Date
2016-01-18
Lead Sponsor
Pamlab, Inc.
Target Recruit Count
238
Registration Number
NCT01990092
Locations
🇺🇸

Arizona Research Center, Phoenix, Arizona, United States

🇺🇸

Collaborative Neuroscience Network, LLC, Long Beach, California, United States

🇺🇸

Center for Clinical Research, Inc., San Francisco, California, United States

and more 22 locations

Effect of Cerefolin®/CerefolinNAC® on Biomarker Measurements

First Posted Date
2012-12-10
Last Posted Date
2015-04-28
Lead Sponsor
Pamlab, Inc.
Target Recruit Count
121
Registration Number
NCT01745198
Locations
🇺🇸

Hoag Memorial Hospital, Newport Beach, California, United States

A Retrospective Analysis of Cerefolin NAC® in Cognitively Impaired Patients

First Posted Date
2012-05-09
Last Posted Date
2014-03-24
Lead Sponsor
Pamlab, Inc.
Target Recruit Count
700
Registration Number
NCT01594541
Locations
🇺🇸

Clionsky Neuro Systems, Inc., Springfield, Massachusetts, United States

NAC-003 P.L.U.S. Program (Progress Through Learning Understanding & Support)

First Posted Date
2011-06-10
Last Posted Date
2013-05-09
Lead Sponsor
Pamlab, Inc.
Target Recruit Count
204
Registration Number
NCT01370954
Locations
🇺🇸

Falls Neurology and Memory Center, Hickory, North Carolina, United States

Deplin® P.L.U.S. Program (Progress Through Learning Understanding & Support)

Completed
Conditions
Interventions
First Posted Date
2011-06-08
Last Posted Date
2014-06-03
Lead Sponsor
Pamlab, Inc.
Target Recruit Count
554
Registration Number
NCT01369030
Locations
🇺🇸

Moses Cone Family Practice Center, Greensboro, North Carolina, United States

🇺🇸

Vanderbilt University School of Medicine, Nashville, Tennessee, United States

Néevo®/NéevoDHA® P.L.U.S. Program (Progress Through Learning, Understand & Support)

Terminated
Conditions
Interventions
First Posted Date
2011-05-23
Last Posted Date
2013-05-01
Lead Sponsor
Pamlab, Inc.
Target Recruit Count
53
Registration Number
NCT01358552
Locations
🇺🇸

Noe Lira, M.D., Corpus Christi, Texas, United States

A Placebo-Controlled Study of Physiologic Effects of L-methylfolate in Schizophrenia Patients

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2010-03-24
Last Posted Date
2016-08-03
Lead Sponsor
Pamlab, Inc.
Target Recruit Count
55
Registration Number
NCT01091506
Locations
🇺🇸

Massachusetts General Hospital (MGH) Schizophrenia Program at Freedom Trail Clinic, Boston, Massachusetts, United States

A Retrospective Analysis of Neevo®/Neevo®DHA Compared to a Standard Prenatal Vitamin in Anemia During Pregnancy

First Posted Date
2010-02-04
Last Posted Date
2013-04-16
Lead Sponsor
Pamlab, Inc.
Target Recruit Count
100
Registration Number
NCT01062958
Locations
🇺🇸

Women's Health Associates, Flowood, Mississippi, United States

🇺🇸

Women's Clinic Shoals, Sheffield, Alabama, United States

🇺🇸

Gainesville Obstetrics & Gynecology, Gainesville, Texas, United States

Combination Deplin® and Antidepressant Therapy for a Major Depressive Episode (MDE)- a Retrospective Analysis

First Posted Date
2009-10-26
Last Posted Date
2013-12-19
Lead Sponsor
Pamlab, Inc.
Target Recruit Count
242
Registration Number
NCT01001559
Locations
🇺🇸

Red Oak Psychiatry Associates, PA, Houston, Texas, United States

Study of Metanx® in Subjects With Type 2 Diabetic Peripheral Neuropathy (DPN)

First Posted Date
2008-08-01
Last Posted Date
2013-08-30
Lead Sponsor
Pamlab, Inc.
Target Recruit Count
214
Registration Number
NCT00726713
Locations
🇺🇸

Tulane University Health Sciences Center, New Orleans, Louisiana, United States

🇺🇸

dgd Research, Inc., San Antonio, Texas, United States

🇺🇸

University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, United States

and more 3 locations
© Copyright 2024. All Rights Reserved by MedPath